Study on Interleukin-7 (CYT107) in HIV Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
HIV
Interventions
BIOLOGICAL

Interleukin-7

20 µg/kg/week. 3 administrations, 1 per week (1 cycle) repeated cycles based on a CD4-guided response

Trial Locations (4)

20892

Niaid/Nih, Bethesda

33136

University of Miami School of Medicine, Miami

44106

Case Western Reserve University, Cleveland

H2X 2P4

McGill University Health Center (MUHC), Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cytheris SA

INDUSTRY